Regulatory Spine Karolinska Development’s portfolio company OssDsign has received FDA clearance for a new major indication byJosh SandbergSeptember 19, 2023
Biologics Spine Karolinska Development’s portfolio company OssDsign has published a case report from the TOP FUSION study in a scientific journal byJosh SandbergJanuary 4, 2023
Spine Karolinska Development’s portfolio company OssDsign completes patient enrollment to the TOP FUSION study byChris StewartApril 25, 2022
Regulatory Spine Karolinska Development’s portfolio company Promimic receives FDA approval for its HAnano Surface® on a spinal implant byChris StewartAugust 28, 2019
